M&A Deal Summary |
|
---|---|
Date | 2013-12-01 |
Target | CircuLite |
Sector | Medical Products |
Buyer(s) | HeartWare International |
Sellers(s) | Omnes Capital |
Deal Type | Add-on Acquisition |
Deal Value | 30M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Medical Products |
Employees | 625 |
Revenue | 262M USD (2016) |
HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure. Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options. HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.
DEAL STATS | # |
---|---|
Overall | 2 of 3 |
Sector (Medical Products) | 2 of 3 |
Type (Add-on Acquisition) | 2 of 3 |
State (New Jersey) | 1 of 1 |
Country (United States) | 2 of 2 |
Year (2013) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-03-29 |
World Heart
Salt Lake City, Utah, United States WorldHeart is a developer of mechanical circulatory support systems based in Salt Lake City, Utah. |
Buy | $8M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-09-01 |
Valtech Cardio
Yehuda, Israel Valtech Cardio Ltd. is specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases – mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR). |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 2004 |
PE ASSETS | 5.7B EUR |
Size | Mega |
Type | Sector Agnostic |
Omnes Capital formerly known as Credit Agricole Private Equity (CAPE) is the investment arm of financial services group Credit Agricole. Omnes Capital looks to invest in a range of investment stages and transaction types, including LBO/expansion, venture capital, mezzanine, renewable energy, co-investment, infrastructure, and special situations. The Firm's LBO/expansion group looks to invest €25 to €80 million to support growth initiatives and buyouts of small and mid-cap businesses operating in a variety of industries. Omnes Capital generally invests in businesses operating in France and Italy. Omnes Capital's mezzanine area was formed in 2002 and looks to provide €5 to €30 million of junior capital to similar sized established businesses. In addition to Omnes Capital's traditional equity and subordinated debt investment arm, the Firm also invests in infrastructure projects as well as provides capital for distressed businesses with €10 to €150 million in revenue. Omnes Capital was formed in 2004 and is based in Paris.
DEAL STATS | # |
---|---|
Overall | 57 of 115 |
Sector (Medical Products) | 2 of 2 |
Type (Add-on Acquisition) | 27 of 52 |
State (New Jersey) | 1 of 1 |
Country (United States) | 5 of 7 |
Year (2013) | 8 of 9 |
Size (of disclosed) | 15 of 16 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-11-22 |
Numericable-SFR
Paris, France Numericable-SFR is the cable operator providing digital television, broadband and telephony services to the residential market ('B2C'). The company also serves the enterprise market ('B2B') in France, Belgium, and Luxembourg. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-12-11 |
Moncler
Milan , Italy Moncler is a manufacturer of high-end sportswear products under the brands Moncler, Henry Cotton, Marina Yachting and Coast, Weber & Ahaus (CWA) and licensee of the second-line brand Cerruti. Moncler was founded in 1952 and is based in Milan, Italy. |
Sell | - |